A
Andrew D. Krahn
Researcher at University of British Columbia
Publications - 273
Citations - 12020
Andrew D. Krahn is an academic researcher from University of British Columbia. The author has contributed to research in topics: Medicine & Sudden cardiac death. The author has an hindex of 59, co-authored 237 publications receiving 10653 citations. Previous affiliations of Andrew D. Krahn include Canadian Cardiovascular Society & London Health Sciences Centre.
Papers
More filters
Journal ArticleDOI
2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Win Kuang Shen,Robert S. Sheldon,David G. Benditt,Mitchell I. Cohen,Daniel E. Forman,Zachary D. Goldberger,Blair P. Grubb,Mohamed H. Hamdan,Andrew D. Krahn,Mark S. Link,Brian Olshansky,Satish R. Raj,Roopinder K. Sandhu,Dan Sorajja,Benjamin C. Sun,Clyde W. Yancy +15 more
TL;DR: This document was approved by the American College of Cardiology Cli American Heart Association Science Advisory and Coordinating Committe Rhythm Society Board of Trustees in January 2017.
Journal ArticleDOI
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.
Christian van der Werf,Prince J. Kannankeril,Frederic Sacher,Andrew D. Krahn,Sami Viskin,Antoine Leenhardt,Wataru Shimizu,Naokata Sumitomo,Frank A. Fish,Zahurul A. Bhuiyan,Albert R. Willems,Maurits J. van der Veen,Hiroshi Watanabe,Julien Laborderie,Michel Haïssaguerre,Bjorn C. Knollmann,Arthur A.M. Wilde +16 more
TL;DR: Flecainide reduced exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia not controlled by conventional drug therapy.
Journal ArticleDOI
Pacemaker therapy in patients with neurally mediated syncope and documented asystole:Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial
Michele Brignole,Carlo Menozzi,Angel Moya,Dietrich Andresen,Jean Jacques Blanc,Andrew D. Krahn,Wouter Wieling,Xulio Beiras,Jean Claude Deharo,Vitantonio Russo,Marco Tomaino,Richard Sutton +11 more
TL;DR: In this paper, a double-blind, randomized placebo-controlled study was conducted in 29 centers in the Third International Study on Syncope of Uncertain Etiology (ISSUE-3) trial.
Journal ArticleDOI
Systematic Assessment of Patients With Unexplained Cardiac Arrest Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER)
Andrew D. Krahn,Jeff S. Healey,Vijay S. Chauhan,David H. Birnie,Christopher S. Simpson,Jean Champagne,Martin J. Gardner,Shubhayan Sanatani,Derek V. Exner,George Klein,Raymond Yee,Allan C. Skanes,Lorne J. Gula,Michael H. Gollob +13 more
TL;DR: Systematic clinical testing results in unmasking of the cause of apparently unexplained cardiac arrest in >50% of patients, and this approach assists in directing genetic testing to diagnose genetically mediated arrhythmia syndromes, which results in successful family screening.
Journal ArticleDOI
Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories.
Paul A. Gould,Andrew D. Krahn +1 more
TL;DR: ICD generator replacement in patients with advisory devices is associated with a substantial rate of complications, including death, and these complications need to be considered in the development of guidelines determining the appropriate treatment of patients with Advisory devices.